CELECOXIB
| SMILES | Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 |
| InChIKey | RZEKVGVHFLEQIL-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 4 |
| Hydrogen bond donors | 1 |
| Rotatable bonds | 3 |
| Molecular weight (Da) | 381.1 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 6.16 | 6.16 | 6.16 | ChEMBL |
| β3 | ADRB3 | Human | Adrenoceptors | A | pKi | 4.92 | 4.92 | 4.92 | ChEMBL |
| D1 | DRD1 | Human | Dopamine | A | pKi | 4.85 | 4.85 | 4.85 | ChEMBL |
| A3 | AA3R | Human | Adenosine | A | pKi | 4.86 | 4.86 | 4.86 | ChEMBL |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 8.21 | 8.21 | 8.21 | Drug Central |
| β3 | ADRB3 | Human | Adrenoceptors | A | pKi | 8.31 | 8.31 | 8.31 | Drug Central |
| D1 | DRD1 | Human | Dopamine | A | pKi | 8.31 | 8.31 | 8.31 | Drug Central |
| A3 | AA3R | Human | Adenosine | A | pKi | 8.31 | 8.31 | 8.31 | Drug Central |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| α2B | ADA2B | Human | Adrenoceptors | A | pIC50 | 5.82 | 5.82 | 5.82 | ChEMBL |
| β3 | ADRB3 | Human | Adrenoceptors | A | pIC50 | 4.79 | 4.79 | 4.79 | ChEMBL |
| D1 | DRD1 | Human | Dopamine | A | pIC50 | 4.55 | 4.55 | 4.55 | ChEMBL |
| A3 | AA3R | Human | Adenosine | A | pIC50 | 4.61 | 4.61 | 4.61 | ChEMBL |
| TSH | TSHR | Human | Glycoprotein hormone | A | Potency | 6.1 | 6.1 | 6.1 | ChEMBL |